Musculoskeletal Diseases II Lecture Notes - PDF
Document Details
Uploaded by VeritableAzurite
Bluefield University
Tags
Related
- Rheumatoid Arthritis: Musculoskeletal Diseases II Lectures
- Musculoskeletal and Autoimmune Evaluation PDF
- Musculoskeletal System Disorders PDF
- PHSI N203F Orthopaedics and Musculoskeletal Physiotherapy I Lecture 4b PDF
- Bones and Joints PDF
- Obat Anti Reumatik, Gout, Muscle Relaxant, dan Osteoporosis PDF
Summary
This document presents lecture notes on musculoskeletal diseases, particularly spondyloarthropathies, covering various aspects such as causes, symptoms, and treatment. It delves into specific conditions like psoriatic arthritis and ankylosing spondylitis, discussing their characteristics and diagnosis.
Full Transcript
Spondyloarthropathy • Family of inflammatory rheumatic diseases that cause arthritis • They involve the “entheses” – where ligaments and tendons attach to bones • Includes: – Psoriatic arthritis – Ankylosing spondylitis (AS) Environmental trigger Susceptible host – Reactive arthritis – Enteropathi...
Spondyloarthropathy • Family of inflammatory rheumatic diseases that cause arthritis • They involve the “entheses” – where ligaments and tendons attach to bones • Includes: – Psoriatic arthritis – Ankylosing spondylitis (AS) Environmental trigger Susceptible host – Reactive arthritis – Enteropathic arthritis associated with IBD (e.g., Crohn’s disease, ulcerative colitis) • Manifestations can overlap. Shared tendency to develop inflammation and calcification of entheses and new bone formation • Other spondyloathropathies share association with HLA-B27, but lower incidence than with AS Disease Spondyloarthropathies and HLA-B27 Molecular Mimicry? Population or Disease Entity * * * HLA-B27 –Positive Healthy whites 8% Healthy African Americans 4% Ankylosing spondylitis (whites) 92% Ankylosing spondylitis (African Americans) 50% Reactive arthritis 60-80% Psoriasis associated with spondylitis 60% IBD associated with spondylitis 60% Isolated acute anterior uveitis 50% Undifferentiated spondyloarthropathy 20-25% Psoriatic arthritis 10-30% Psoriatic Arthritis The Start: Psoriasis • Silvery scale on extensor surfaces (esp. knees and elbows) • Very common – prevalence of 1-8.5% of adults Pathophysiology of Psoriatic Arthritis • Inflammatory arthritis – progressive disease with joint erosion • Seen in up to 30% of psoriasis patients (onset of psoriasis 1st) ‒ Median onset of psoriasis – 27-31 yoa ‒ Median onset of arthritis – 38-52 yoa ‒ 15% of patients have arthritis first, then psoriasis • Strong association w/ HLA-Cw6 – Early onset of psoriasis and more extensive/severe disease – Also, association of articular symptoms to HLA-B proteins (27, 38, 39) • Environmental trigger – Possible association w/ streptococcal infection • Cell-mediated response – CD4, CD8, macs, PMNs Signs and Symptoms of Psoriatic Arthritis Spine and Digits • Enthesitis – common presenting symptom – Most common at Achilles and plantar fascia insertion • Dactylitis – “sausage” shaped fingers or toes – Common presenting symptom • Tenosynovitis • Asymmetric oligo-arthritis • Spondylitis • Morning stiffness – usually lasting more than 30 minutes, improves with activity and worsens with immobility Psoriatic Arthritis: Patterns of Joint Involvement 1. 2. 3. 4. 5. Symmetric polyarthritis (45%) Asymmetric mono/oligo-arthritis (30%) Distal interphalangeal (DIP) joint involvement (5%) Axial spondylitis/sacroilitis (5%) Arthritis mutilans (<5%) Imaging in Psoriatic Arthritis (PsA) X-ray: Bony erosion and resorption together cause “pencil in cup” deformity, joint space narrowing, entheseal sites (bony spurs, periostitis) Extra-Articular Signs and Symptoms of PsA • Plaque psoriasis (psoriasis vulgaris) – most common • Nail changes – Nail pitting, onycholysis, nail bed hyperkeratosis, and splinter hemorrhages • Fatigue • Uveitis or iritis – rare Diagnosing Psoriatic Arthritis There is no specific lab test. • Usually RF-negative, but a few pts may be positive for RF, anti-CCP, or ANA • Nonspecific signs of inflammation – ESR and CRP • X-rays – “gold standard” to assess bony changes CASPAR = Classification of Psoriatic Arthritis Study Group Criteria • Skin Psoriasis ‒ Present – 2 points ‒ Previously present by history – 1 point ‒ Family history of psoriasis – 1 point • Nail lesions (onycholysis, pitting) – 1 point • Dactylitis (onycholysis, pitting) – 1 point • Negative rheumatoid factor (RF) – 1 point • Juxta-articular bone formation on radiographs – 1 point Treating Psoriatic Arthritis • DMARDs (methotrexate, cyclosporine, sulfasalazine, leflunomide) • Biologics also available – etanercept (Enbrel™), infliximab, adalimumab (Humira™), etc. Which One Is It? https://www.semanticscholar.org/paper/Psoriatic-arthritis%3A-state-of-the-art-review-Coates-Helliwell/bcefecc5023211ff3fa4345ddc99a33fb52b94bb Ankylosing Spondylitis The Basics of Ankylosing Spondylitis (AS) • Chronic systemic inflammatory disease of the axial skeleton with involvement of peripheral joints and non-articular structures • Mainly affects the sacroiliac joint and pelvis, causing eventual fusion of the spine • If the spine completely fuses, “bamboo spine” • Enthesis = the site of attachment of a muscle or ligament to bone https://images.ctfassets.net/oc83wx5cwffk/spu_wysiwyg_fid36479_asset/3c348576e94e34a032e5985fa7 9237e2/ankylosing_spondylitis11222989_M.jpg https://prod-imagesstatic.radiopaedia.org/images/56055054/ankylosing_spondylitis_jumbo.jpeg Epidemiology of AS • Prevalence in US ~0.5% (varies w/ prevalence of HLA-B27 gene) • Male:female = 3:1 • Onset – late teens to 40 years; long delay in diagnosis • Racial difference due to gene distribution ‒ 90% of white pts with AS have HLA-B27 ‒ <1% of African blacks and Japanese are HLA-B27+ • Image: Imagine Dragon’s Dan Reynolds. He was diagnosed when he was 20 years old. • https://www.practicalpainmanagement.com/patient/conditions/low-back-pain/imagine-dragons-dan-reynoldsbreaks-his-silence-about-ankylosing (Tells about his presentation) Pathophysiology of AS Enthesitis with chronic inflammation of vertebrae, esp. sacroiliac (SI) joint • TNF-α and IL-1 contribute to disease pathogenesis • More of a cell-mediated response (CD4 and CD8) than of auto-antibodies • Inflammation causes release of matrix metalloproteinases (MMPs) • MMPs then erode the fibrocartilage • As repair begins, scar tissue ossifies, calcifies, and fuses the joint. https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00281-021-00838-z/MediaObjects/281_2021_838_Fig1_HTML.png Signs and Symptoms of AS • Early symptoms – Pain and stiffness, usually in the middle or lower back, mainly in SI joint – prevailing diagnostic feature o Inflammatory back pain is the most common symptom and the first manifestation in ~ 75% of patients o Morning stiffness – min 30 min. (as long as 3 hrs) o Worse at night o No improvement with rest o Chronic = > 3 mo – Usually no swelling, except at Achilles insertion – Extra-articular signs/symptoms: uveitis, IBD, psoriasis • Later symptoms – Fusion of vertebrae = bamboo spine – Lose normal posture Diagnosing Ankylosing Spondylitis • Diagnosis based on history + physical exam + X-rays • Difficult to diagnose • Usually, 8-11 yr lag time between onset of symptoms and diagnosis • Imaging – X-ray of pelvis or MRI if X-rays are non-diagnostic • Lab – no lab test is diagnostic – HLA-B27 may be helpful – ESR and/or CRP – general markers of inflammation The Picture of Ankylosing Spondylitis Grade 0 – normal Grade 4 –complete fusion Treatment of Ankylosing Spondylitis • Goal: maintain function, prevent complications, relieve symptoms • NSAIDs – first line • Analgesia – Opioid analgesics – minimize use, but may use as required – Local corticosteroid injections – may be helpful – Systemic corticosteroids – may control flares, but should use only short-term • TNF inhibitors such as etanercept, infliximab, golimumab, adalimumab • Joint replacement, especially if it affects knees or hips • Non-pharmaceutical – exercise, physical therapy, STOP SMOKING (see notes)